Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANI PHARMACEUTICALS INCANIP · Entity 4638 | Director | March 28, 2019 | April 01, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANI PHARMACEUTICALS INC
Report date March 28, 2019 · Filed April 01, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,301 |
Reported balance
After 2019-03-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-03-28 · Grant · Acquired 1,991 · Balance 14,301 F1: The restricted stock and stock options vest on March 28, 2020. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $66.39 · Expires 2029-03-27 | Direct | 2,409 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Grant · Acquired 2,409 · Balance 2,409 F1: The restricted stock and stock options vest on March 28, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock and stock options vest on March 28, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2019 Filed Apr 1, 2019 20:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 2,409 | $0.00 Strike: $66.39 | $0.00 |
DisclosureSEC source: 0001144204-19-017402 · tv517655_4.xml · derivative · entry 2 Penn Thomas A. · CIK 0001579590 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,409 Underlying: Common Stock · 2,409 shares Expires 2029-03-27 F1 · security: The restricted stock and stock options vest on March 28, 2020. F1 · derivative.exercise_date: The restricted stock and stock options vest on March 28, 2020. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 1,991 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-017402 · tv517655_4.xml · nonDerivative · entry 1 Penn Thomas A. · CIK 0001579590 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,301 F1 · security: The restricted stock and stock options vest on March 28, 2020. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 20:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 1,475 | $0.00 Strike: $65.86 | $0.00 |
DisclosureSEC source: 0001144204-18-033527 · tv496173_4.xml · derivative · entry 2 Penn Thomas A. · CIK 0001579590 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475 Underlying: Common Stock · 1,475 shares Expires 2028-06-05 F1 · security: The restricted stock and stock options vest on May 17, 2019. F1 · derivative.exercise_date: The restricted stock and stock options vest on May 17, 2019. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 20:01 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-033527 · tv496173_4.xml · nonDerivative · entry 1 Penn Thomas A. · CIK 0001579590 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,310 F1 · security: The restricted stock and stock options vest on May 17, 2019. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:10 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Options · Derivative | 2,000 | $0.00 Strike: $49.51 | $0.00 |
DisclosureSEC source: 0001144204-17-018965 · v463553_form4.xml · derivative · entry 2 Penn Thomas A. · CIK 0001579590 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2027-03-30 F1 · security: The restricted stock and stock options vest on the first anniversary of the grant date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:10 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-018965 · v463553_form4.xml · nonDerivative · entry 1 Penn Thomas A. · CIK 0001579590 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,110 F1 · security: The restricted stock and stock options vest on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.